Association between cognition and serum insulin-like growth factor-1 in middle-aged & older men: An 8 year follow-up study

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Tumati, Shankar ^a   Burger, Huibert ^a   Martens, Sander ^a   Van Der Schouw, Yvonne T ^b   Aleman, André ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; SOMATOMEDIN C;

ADULT; AGE; AGED; ARTICLE; BODY MASS; COGNITION; CONTROLLED STUDY; CORRELATIONAL STUDY; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MEMORY; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PHYSICAL ACTIVITY; PROCESSING CAPACITY; PROTEIN BLOOD LEVEL; SMOKING; BLOOD; COGNITIVE DYSFUNCTION; GENE EXPRESSION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COGNITION; COGNITIVE DYSFUNCTION; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 84977485778     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154450     Document Type: Article

References (45)

1. Stuck AE, Walthert JM, Nikolaus T, Bula CJ, Hohmann C, Beck JC. Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med. 1999; 48: 445-469. PMID: 10075171
2. Salthouse TA. When does age-related cognitive decline begin? Neurobiol Aging. 2009; 30: 507-514. doi: 10.1016/j.neurobiolaging.2008.09.023 PMID: 19231028
3. Morley JE, Kaiser F, Raum WJ, Perry HM 3rd, Flood JF, Jensen J, et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci U S A. 1997; 94: 7537-7542. PMID: 9207127
4. Rollero A, Murialdo G, Fonzi S, Garrone S, Gianelli MV, Gazzerro E, et al. Relationship between cognitive function, growth hormone and insulin-like growth factor I plasma levels in aged subjects. Neuropsychobiology. 1998; 38: 73-79. PMID: 9732206
5. Aleman A, Verhaar HJ, De Haan EH, De Vries WR, Samson MM, Drent ML, et al. Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab. 1999; 84: 471-475. PMID: 10022403
6. Aleman A, de Vries WR, Koppeschaar HP, Osman-Dualeh M, Verhaar HJ, Samson MM, et al. Relationship between circulating levels of sex hormones and insulin-like growth factor-1 and fluid intelligence in older men. Exp Aging Res. 2001; 27: 283-291. PMID: 11441649
7. Landi F, Capoluongo E, Russo A, Onder G, Cesari M, Lulli P, et al. Free insulin-like growth factor-I and cognitive function in older persons living in community. Growth Horm IGF Res. 2007; 17: 58-66. PMID: 17208483
8. Dik MG, Pluijm SM, Jonker C, Deeg DJ, Lomecky MZ, Lips P. Insulin-like growth factor I (IGF-I) and cognitive decline in older persons. Neurobiol Aging. 2003; 24: 573-581. PMID: 12714114
9. Kalmijn S, Janssen JA, Pols HA, Lamberts SW, Breteler MM. A prospective study on circulating insulinlike growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J Clin Endocrinol Metab. 2000; 85: 4551-4555. PMID: 11134107
10. Okereke OI, Kang JH, Ma J, Gaziano JM, Grodstein F. Midlife plasma insulin-like growth factor I and cognitive function in older men. J Clin Endocrinol Metab. 2006; 91: 4306-4312. PMID: 16912125
11. Aleman A, Torres-Aleman I. Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan. Prog Neurobiol. 2009; 89: 256-265. doi: 10.1016/j.pneurobio.2009.07.008 PMID: 19665513
12. Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE, van der Schouw YT. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol. 2003; 149: 583-589. PMID: 14641001
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189-198. PMID: 1202204
14. Lezak MD, editor. Neuropsychological Assessment. 3rd ed. New York: Oxford University Press; 1995.
15. Davis C, Bradshaw CM, Szabadi E. The Doors and People Memory Test: Validation of norms and some new correction formulae. British Journal of Clinical Psychology. 1999; 38: 305-314. PMID: 10532152
16. Wechsler D. A standardized memory scale for clinical use. Psychology. 1945; 19: 87-95.
17. Muller M, Aleman A, Grobbee DE, de Haan EH, van der Schouw YT. Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level? Neurology. 2005; 64: 866-871. PMID: 15753424
18. Verhage F. Intelligentie en leeftijd. Onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar. Assen: Van Gorcum; 1964.
19. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA. A physical activity questionnaire for the elderly. Med Sci Sports Exerc. 1991; 23: 974-979. PMID: 1956274
20. van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate Imputation by Chained Equations in R. Journal of Statistical Software. 2011; 45: 1-67.
21. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Statistics in Medicine. 2011; 30: 377-399-378-399.
22. Rubin DB. Multiple Imputation for Nonresponse in Surveys: John Wiley & Sons; 2009.
23. Arwert LI, Deijen JB, Drent ML. The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Horm IGF Res. 2005; 15: 416-422. PMID: 16256385
24. Deijen JB, Arwert LI, Drent ML. The GH/IGF-I Axis and Cognitive Changes across a 4-Year Period in Healthy Adults. ISRN Endocrinol. 2011; 2011: 249421. doi: 10.5402/2011/249421 PMID: 22363870
25. Al-Delaimy WK, von Muhlen D, Barrett-Connor E. Insulinlike growth factor-1, insulinlike growth factor binding protein-1, and cognitive function in older men and women. J Am Geriatr Soc. 2009; 57: 1441-1446. doi: 10.1111/j.1532-5415.2009.02343.x PMID: 19515112
26. Licht CM, van Turenhout LC, Deijen JB, Koppes LL, van Mechelen W, Twisk JW, et al. The Association between IGF-1 Polymorphisms, IGF-1 Serum Levels, and Cognitive Functions in Healthy Adults: The Amsterdam Growth and Health Longitudinal Study. Int J Endocrinol. 2014; 2014: 181327. doi: 10.1155/ 2014/181327 PMID: 25114679
27. Bayram F, Gedik VT, Demir O, Kaya A, Gundogan K, Emral R, et al. Epidemiologic survey: reference ranges of serum insulin-like growth factor 1 levels in Caucasian adult population with immunoradiometric assay. Endocrine. 2011; 40: 304-309. doi: 10.1007/s12020-011-9476-z PMID: 21538205
28. Angelini A, Bendini C, Neviani F, Bergamini L, Manni B, Trenti T, et al. Insulin-like growth factor-1 (IGF-1): relation with cognitive functioning and neuroimaging marker of brain damage in a sample of hypertensive elderly subjects.Arch Gerontol Geriatr. 2009; 49 Suppl 1: 5-12. doi: 10.1016/j.archger.2009.09. 006 PMID: 19836610
29. Bidlingmaier M, Friedrich N, Emeny RT, Spranger J, Wolthers OD, Roswall J, et al. reference intervals for insulin-like growth factor-1 (igf-1) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J Clin Endocrinol Metab. 2014; 99: 1712-1721. doi: 10.1210/jc.2013-3059 PMID: 24606072
30. Vardy ER, Rice PJ, Bowie PC, Holmes JD, Grant PJ, Hooper NM. Increased circulating insulin-like growth factor-1 in late-onset Alzheimer's disease. J Alzheimers Dis. 2007; 12: 285-290. PMID: 18198415
31. Johansson P, Åberg D, Johansson J, Mattsson N, Hansson O, Ahrén B, et al. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease. Psychoneuroendocrinology. 2013; 38: 1729-1737. doi: 10.1016/j. psyneuen.2013.02.006 PMID: 23473966
32. van Exel E, Eikelenboom P, Comijs H, Deeg DJH, Stek ML, Westendorp RGJ. Insulin-like growth factor-1 and risk of late-onset Alzheimer's disease: findings from a family study. Neurobiol Aging. 2014; 35: 725.e7-725.e10.
33. de Bruijn RF, Janssen JA, Brugts MP, van Duijn CM, Hofman A, Koudstaal PJ, et al. Insulin-like growth factor-I receptor stimulating activity is associated with dementia. J Alzheimers Dis. 2014; 42(1):137-42. doi: 10.3233/JAD-140186 PMID: 24820016
34. Duron E, Funalot B, Brunel N, Coste J, Quinquis L, Viollet C, et al. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease. J Clin Endocrinol Metab. 2012; 97: 4673-4681. doi: 10.1210/jc.2012-2063 PMID: 23015654
35. Doi T, Shimada H, Makizako H, Tsutsumimoto K, Hotta R, Nakakubo S, et al. Association of insulin-like growth factor-1 with mild cognitive impairment and slow gait speed. Neurobiol Aging. 2015; 36: 942-947. doi: 10.1016/j.neurobiolaging.2014.10.035 PMID: 25467636
36. Westwood AJ, Beiser A, Decarli C, Harris TB, Chen TC, He XM, et al. Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. Neurology. 2014; 82: 1613-1619. doi: 10.1212/WNL. 0000000000000382 PMID: 24706014
37. Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD, Craft S, et al. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch Neurol. 2012; 69: 1420-1429. PMID: 22869065
38. Fernandez AM, Torres-Aleman I. The many faces of insulin-like peptide signalling in the brain. Nat Rev Neurosci. 2012; 13: 225-239. doi: 10.1038/nrn3209 PMID: 22430016
39. Matousek RH, Sherwin BB. Sex steroid hormones and cognitive functioning in healthy, older men. Horm Behav. 2010; 57: 352-359. doi: 10.1016/j.yhbeh.2010.01.004 PMID: 20079740
40. Deak F, Sonntag WE. Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. J Gerontol A Biol Sci Med Sci. 2012; 67: 611-625. doi: 10.1093/gerona/gls118 PMID: 22503992
41. Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ, et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A. 2008; 105: 3438-3442. doi: 10. 1073/pnas.0705467105 PMID: 18316725
42. Euser SM, van Heemst D, van Vliet P, Breteler MM, Westendorp RG. Insulin/Insulin-like growth factor-1 signaling and cognitive function in humans. J Gerontol A Biol Sci Med Sci. 2008; 63: 907-910. PMID: 18840794
43. Bassil F, Fernagut P, Bezard E, Meissner WG. Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification? Prog Neurobiol. 2014; 118: 1-18. doi: 10.1016/j. pneurobio.2014.02.005 PMID: 24582776
44. Sievers C, Auer MK, Klotsche J, Athanasoulia AP, Schneider HJ, Nauck M, et al. IGF-I levels and depressive disorders: results from the Study of Health in Pomerania (SHIP). Eur Neuropsychopharmacol. 2014; 24: 890-896. doi: 10.1016/j.euroneuro.2014.01.008 PMID: 24507017
45. Sun LY, Al-Regaiey K, Masternak MM, Wang J, Bartke A. Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol Aging. 2005 Jun; 26(6):929-37. PMID: 15718052